The Patent Finder

Elorac, Inc.

Also on record
Records under this name other than patents Elorac, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 10 of 10 · Back to Elorac, Inc.

PatentTitleStatus Expires Confidence
US 11,478,439Method for alleviating keratoconjunctivitis sicca
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,166,925Method for alleviating keratoconjunctivitis sicca
Formerly held
Lapsed on the fee record
Ended Nov 9, 2025 · From the USPTO record
Lapsed on the fee recordEnded Nov 9, 2025From the USPTO record
US 7,371,367Method of treating inflammatory acne vulgaris and rosacea with carbamide peroxide
Formerly held
Term ended
Term ended Aug 6, 2025 · From the USPTO record
Term endedTerm ended Aug 6, 2025From the USPTO record
US 9,545,419Method and compositions for treating chronic inflammatory disorders
Formerly held
Lapsed on the fee record
Ended Jan 17, 2025 · From the USPTO record
Lapsed on the fee recordEnded Jan 17, 2025From the USPTO record
US 9,238,017Compositions with reduced hepatotoxicity
Formerly held
Term ended
Term ended Sep 25, 2024 · From the USPTO record
Term endedTerm ended Sep 25, 2024From the USPTO record
US 7,244,446Method for providing long-lasting pain diminishment through topical or intranasal administration of civamide
Formerly held
Term ended
Term ended Oct 16, 2023 · From the USPTO record
Term endedTerm ended Oct 16, 2023From the USPTO record
US 7,772,275Compositions and method for treating affective, painful or allergic disorders
Formerly held
Term ended
Ended no later than Nov 14, 2022 · From the USPTO record
Term endedEnded no later than Nov 14, 2022From the USPTO record
US 8,604,047Method and composition for treating nodulocystic and conglobate acne vulgaris
Lapsed on the fee record
Ended Dec 10, 2021 · From the USPTO record
Lapsed on the fee recordEnded Dec 10, 2021From the USPTO record
US 7,629,378Compositions and method for treating affective, painful or allergic disorders
Lapsed on the fee record
Ended Dec 8, 2021 · From the USPTO record
Lapsed on the fee recordEnded Dec 8, 2021From the USPTO record
US 4,505,896Method of treating acne vulgaris and composition
Term ended
Term ended no later than Mar 19, 2005 · Low confidence
Term endedTerm ended no later than Mar 19, 2005Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited